SCHEMBL16359

SCHEMBL16359

CC(O)(c1ccc(N2CCN(S(=O)(=O)c3cccs3)C[C@@H]2COCc2cccnc2)cc1)C(F)(F)F

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 9/20 0.64
GCKR Q14397 11/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18281 1.00 GCK (0.64) GCKGCKR
SCHEMBL12079075 1.00 GCK (0.64) GCKGCKR
SCHEMBL12078298 1.00 GCK (0.64) GCKGCKR
SCHEMBL16982 1.00 GCK (0.64) GCKGCKR
SCHEMBL18177 1.00 GCK (0.64) GCKGCKR
SCHEMBL16138 1.00 GCK (0.64) GCKGCKR
SCHEMBL12089730 0.93 GCKR (0.57) GCKGCKR
SCHEMBL12089465 0.93 GCKR (0.57) GCKGCKR
SCHEMBL12089406 0.93 GCKR (0.57) GCKGCKR
SCHEMBL16340 0.91 GCKR (0.68) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed